Mineral-Homeostasis in Continuous Renal Replacement Therapy

N/ACompletedNCT01946113

Heinrich-Heine University, Duesseldorf200 enrolled

Overview

Acute renal failure is a common complication in intensive care unit patients. In 10% of cases renal replacement therapy becomes necessary. Current devices have increase filter patency and efficacy. However, magnesium, calcium and phosphate are eliminated as well. However, the extend of this elimination hase not been quantified. Thus, we want to 1. record retrospectively how often abnormal values for phosphate, magnesium and calcium occurred during routine renal replacement therapy in 2011 and 2012. 2. prospectively evaluate the same parameters during routine treatment in 2013 and 2014

Study Type

OBSERVATIONAL

Enrollment

200

Conditions

Acute Renal Failure

Eligibility

Sex: ALLMin age: 18 Years

Medical Language ↔ Plain English

Inclusion Criteria: * intensive care unit patients with acute renal failure undergoing continuous renal replacement therapy * older than 18 years of age Exclusion Criteria: * age less than 18 years * pregnancy * contraindications against continuous renal replacement therapy

Locations (1)

Interdisziplinäre Intensivstation Universitätsklinikum Düsseldorf

Düsseldorf, Germany

Outcomes

Primary Outcomes

Incidence of hypo-phosphate,-magnesium and calcaemia

Participants will be followed for the duration of ICU stay, an expected average of 28 days

Time frame: approximately 28 days

Data from ClinicalTrials.gov

This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.